secwatch.observer — SEC 8-K summary
======================================

Issuer:     OSR Holdings, Inc. (OSRH)
CIK:        0001840425
Form:       8-K
Filed at:   2023-02-15T23:59:59+00:00
Accession:  0001193125-23-040219
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SPAC Bellevue Life Sciences closes $60M IPO; $61.05M in trust, 9-month deadline for healthcare deal
--------------------------------------------------------------------------------

- IPO of 6,000,000 units at $10/unit raises $60M; each unit comprises one share, one warrant ($11.50 strike), and one right (1/10 share).
- Private placement of 430,000 units to sponsor Bellevue Global Life Sciences Investors LLC raises additional $4.3M.
- Total $61.05M deposited into trust account; funds not released until business combination, amendment vote, or liquidation within 9 months.
- Units trade on Nasdaq under BLACU; common stock, warrants, and rights to trade separately under BLAC, BLACW, and BLACR.
- Company intends to focus on healthcare industry targets for its initial business combination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840425/000119312523040219/0001193125-23-040219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840425/000119312523040219/d466095d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-040219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer